Date&Place of Birth: 1970, Izmir, TURKEY
Office Contact: Acibadem Maslak Hospital Department of Medical Oncology
Büyükdere Cad No:40 Maslak Istanbul TURKEY
Academic
Title&Department:
Associate Professor of Internal Medicine and Medical Oncology,
Acibadem Maslak Hospital, Istanbul, Turkey.
Academic
Qualifications:
1994 MD, Hacettepe University Medical Faculty, Ankara, TR
1999 INTERNAL MEDICINE SPECIALIST, Ankara Numune Hospital, TR
2002 MEDICAL ONCOLOGY SPECIALIST, Erciyes University, TR
2003-2004 MD Anderson Cancer Center, Breast Medical Oncology, USA
2006- 2008 AVON-AACR Cancer Biology Fellow, TJU, USA
Academic Interests: Solid tumors - breast cancer, colorectal cancer, lung cancer, targeted therapy, thrombosis in cancer patients
Researchs/Projects: I have participated in several national and international multicenter
clinical studies.
Experience Abroad: MD Anderson Cancer Center, Medical Oncology Department
October 2003- March 2004 (Clinical observer under supervision of Prof
Gabriel N. Hortobagyi)
Thomas Jefferson University, Philadelphia, PA
2006- 2008 AVON-AACR Cancer Biology Fellow
Memberships: ASCO Associate Member ESMO Full Member (CERTIFICATED)
AACR Member Turkish Oncology Group Member
Awards: 29th ESMO Travel Award (Vienna, 2004)
Clinical Course Of Breast Cancer Patients With Liver Metastases Only
Treated With Chemotherapy. Ozlem Er , Debbie Frye, Kristine Broglio,
Vicente Valero, Gabriel N. Hortobagyi, Banu Arun.
Journal of Thrombosis and Haemostasis 2004 Young Investigator
Prize
A Randomized Clinical Trial Of Combination Chemotherapy With And
Without Low Molecular Weight Heparin In Small Cell Lung Cancer.
Mustafa Altinbas, Hasan Senol Coskun, Ozlem Er, Metin Ozkan, Bulent
Eser, Ali Unal, Mustafa Cetin, Serdar Soyuer.
Avon Foundation-American Association for Cancer Research
International Scholars Award in Breast Cancer Research (2006)
Role of Caveolin in breast cancer pathogenesis
2
Publications A. Papers Published in Peer-Reviewed Journals:
A1. Mustafa Cetin, Yusuf Ozkul, Ali Unal, Bulent Eser, Omer Ozturk,
Recep Kutlubay, Ozlem Er, Hatice Burakgazi. The effect of
medroxyprogesterone acetate on bone marrow and testis during
cytotoxic chemotherapy. Cell Biology and Toxicology, 16, 385-390
(2000);
A2. Mustafa Cetin, Bulent Eser, Ozlem Er, Ali Unal, Mehmet Bilgin.
Extreme thrombocytosis after penetrating femoral venous injury.
Hematology, 6, 69-72 (2001);
A3. Bulent Eser, Mustafa Cetin, Olgun Kontas, Ali Unal, Ozlem Er,
Hasan S Coskun, Mustafa Altınbas. Facial nerve paralysis and paraplagia
as presenting symptoms of acute leukemia. Japan J Clin Oncol 31(2),
86-88 (2001);
A4. Ozlem Er, H.Senol Coskun, Mustafa Altınbas, Hulya Akgun,
Mustafa Cetin, Bulent Eser, Al i Unal. Rapidly relapsing squamous
cell carcinoma of renal pelvis associated with paraneoplastic syndromes
of leukocytosis, thrombocytosis and hypercalcemia. Urologia
Internationalis 67,175-177 (2001);
A5. Mustafa Cetin, Bulent Eser, Ozlem Er, Ali Unal, Eser Kılıc, Tahir
Patıroğlu, Hasan S Coskun, Mustafa Altınbas, Onder Arslan, Osman
İlhan. Effects of DMSO on platelet functions and P-Selectin expression
during storage. Transfusion and Apheresis Science 24, 261-267 (2001);
A6. Isın Soyuer, Serdar Soyuer, Ozlem Canoz, Ozlem Er, Yucel Arıtas.
Correspondence. Cytopathology 13 (3), 177 (2002);
A7. Berna Oksuzoğlu, Ozlem Er, Mehmet Guler,Mutlu Doğanay, Mustafa
Esen, Nuri Aydın Kama. Disseminated high grade malignant lymphoma
involving both of the breasts. The Breast 11:454-456 (2002);
A8. Mustafa Altınbas, Ozlem Er, Metin Ozkan,Hasan S Coskun, İnci
Gulmez, Eyup Ekici, Bunyamin Kaplan, Bulent Eser, Mustafa Ozesmi.
Ifosfamide, mesna and interferon alfa combination
chemoimmunotherapy in malignant mesothelioma:results of a single
center in Central Anatolia. Medical Oncology 21(4):359-366 (2004);
A9. Bunyamin Kaplan, Mustafa Altınbas, Celalettin Eroğlu, Eray
Karahacıoğlu, Ozlem Er, Metin Ozkan, Mehmet Bilgin, Ozlem Canoz, İnci
Gulmez, Mustafa Gulec. Preliminary results of a phase II study of
weekly paclitaxel (PTX) and carboplatin (CBDCA) administered
concurrently with thoracic radiation therapy (TRT) followed by
consolidation chemotherapy with PTX/CBDCA for stage III unresectable
non-small cell lung cancer (NSCLC). American Journal of Clinical
Oncology 27 (6):603-610 (2004);
A10. Metin Ozkan, Mustafa Altinbas, Ozlem Er, Bunyamin Kaplan,
Hasan Senol Coskun, Eray Karahacioğlu, Ahmet Menku, Yasemin Cihan,
Olgun Kontas, Hidayet Akdemir. Post-operative sequential chemoradiotherapy
in high-grade cerebral gliomas with fotemustine. Journal of
Chemotherapy 16 (3):298-302 (2004);
A11. Metin Ozkan, Ozlem Er, Bunyamin Kaplan, Mustafa Altinbas,
Bulent Ozcelik, Fatma Tokat, Edip Torun, Okkes Ibrahim Karahan;
3
Presentation with superior vena cava syndrome secondary to solitary
lung metastasis mimicking primary lung cancer following resection of a
uterine malignant mixed mullerian tumor. Eur J Obs Gyn & Rep Biol 118
(2): 260-264 (2005);
A12. M Ozkan, B Eser, Ozlem Er, F Altuntas, R Coskun, R Topsakal, E
Mavili, M Kala, M Altinbas. Antiphospholipid syndrome associated with
malignant mesothelioma presenting with superior vena cava thrombosis:
A case report. Clin Appl Throm Hemos 10 (4): 393-396 (2004);
A13. Mustafa Altinbas, Hasan S. Coskun, Ozlem Er, Metin Ozkan,
Bulent Eser, Ali Unal, Mustafa Cetin, Serdar Soyuer. A randomized
clinical trial of combination chemotherapy with and without low
molecular weight heparin in small cell lung cancer. J Throm Hemostasis
2 (8): 1266-1271 (2004);
A14. Ozlem Er, Hasan S. Coskun, Mustafa Altinbas, Metin Ozkan,
Bulent Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Meropenem +/-
granulocyte colony stimulating factor in the treatment of febrile
neutropenic patients with cancer: Prospective randomized study.
Journal of Chemotherapy 16 (3):288-292 (2004);
A15. Bulent Eser, Fevzi Altuntas, Ozlem Er, Olgun Kontas, Ayten
Ferahbas, Mustafa Cetin, Ali Unal. A case of subcutaneous panniculitis
like T-cell lymphoma with hemophagocytosis secondary to
chemotherapy. JEADV 18 (6):713-715 (2004);
A16. Gulmez I, Kart L, Buyukoglan H, Er O, Balkanli S, Ozesmi M.
Evaluation of malignant mesothelioma in central Anatolia: a study of 67
cases. Can Respir J 11(4):287-90 (2004);
A17. Mustafa Altinbas, Ozlem Er, Metin Ozkan, Yusuf Solak, H. Senol
Coskun, Can Kucuk, Sebnem Gursoy. Irinotecan Plus Cisplatin
Combination Against Metastatic Gastric Cancer: Phase II Study. Medical
Oncology 2005; 22(2):153-60;
A18. Hasan Senol Coskun, Ozlem Er, Serdar Soyuer, Mustafa Altınbas,
Bulent Eser,Eray Karahacioglu, Fevzi Altuntas. Solitary Plasmacytoma:
Experiences From Central Anatolia. Irish J Med Sci 2005 Jan-
Mar;174(1):33-6;
A19. O. Er, M. Ozkan, M. Altinbas, H.S. Coskun, B. Eser, F. Altuntas, M.
Cetin, A. Unal. “Outpatient 5-fluorouracil+a-interferon+interleukin-2
chemoimmunotherapy in metastatic renal cell cancer patients” Asia-
Pacific J Clin Oncol, 1, 145-150 (2005);
A20. Dogu GG, Ozkan M, Er O, Eser B, Altinbas M. Squamous cell
carcinoma of colorectal cancer: adjuvant radiotherapy is necessary? Eur
J Cancer Care (Engl). 2005 Dec;14(5):465;
A21. M. Ozkan, B. Eser, O. Er, H. S. Coskun, A. Ozturk, I. Sari, O.
Canoz, M. Altinbas. “Bone marrow involvement in small cell lung cancer:
Prognostıc significance and correlation with hematological and
biochemical parameters” Asia–Pacific J Clin Oncol, 2, 32–38 (2006);
A22. B Eser, B Kaplan, A Unal, O Canoz, F Altuntas, HI Sari, Ozlem Er,
Metin Ozkan, Can Kucuk, Makbule Arar, Sebnem Gursoy, and Mustafa
Cetin. Clinicopathologic Characteristics and Therapeutic Outcomes Of
Primary Gastrointestinal Non-Hodgkin’s Lymphomas in Central Anatolia,
4
in Turkey. Yonsei Medical Journal 2006 Feb 28;47 (1):22-33;
A23. Eser B, Sari I, Canoz O, Altuntas F, Cakmak E, Ozturk A, Ozkan M,
Er O, Cetin M, Unal A. Prognostic significance of Fas (CD95/APO-1)
positivity in patients with primary nodal diffuse large B-cell lymphoma.
Am J Hematol. 2006 May;81(5):307-14;
A24. Bulent Eser, Fevzi Altuntas, Işın Soyuer, Ozlem Er, Ozlem Canoz,
Hasan S Coskun, Mustafa Cetin, Ali Unal. Acute Lymphoblastic Leukemia
Associated with Brucellosis in Two Patients with Fever and Pancytopenia.
Yonsei Medical Journal 2006; 47(5): 741-744;
A25. Nihat Kalay, Emrullah Basar, Ibrahim Ozdogru, Ozlem Er, Yakup
Cetinkaya, Ali Dogan, Tugrul Inanc, Abdurrahman Oguzhan, Namik
Kemal Eryol, Ramazan Topsakal, Ali Ergin. Protective effects of carvedilol
against anthracycline-induced cardiomyopathy. J Am Coll Cardiol. 2006
Dec 5;48(11):2258-62;
A26. Ozlem Canoz, Metın Ozkan, Vedat Arsav, Ozlem Er, HS Coskun, S
Soyuer, M Altinbas. The role of c-erbB-2 expression on the survival of
patients with small-cell lung cancer. Lung 2006; 184(5):267-272;
A27. Ozlem Er, Leo R Zacharski. Management of cancer-associated
thrombosis. Vascular Health and Risk Management 2006; 2(4):351-356;
A28. M Sofikerim, I Gulmez, F Tokat, Ozlem Er, I Gulmez. Epidermoid
carcinoma of the lung with isolated penile metastasis. Can J Urol. 2007
Aug;14(4):3643-5;
A29. Yaman E, Uner A, Er O, Coskun U, Buyukberber S, Dikilitas M,
Polat M, Yamac D, Kaya AO, Yildiz R, Ozturk B, Benekli M. Capecitabine
plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients
with metastatic colorectal cancer. Med Oncol. 2007;24(4):431-5;
A30 Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkis N, Coskun
U,Camci C, Buyukberber S. Gemcitabine plus Capecitabine Combination
in Metastatic Breast Cancer Patients Previously Treated with
Anthracyclines and Taxanes. Oncology. 2007;72(5-6):308-313;
A31 O Er, DK Frye, SC Kau, K Broglio, V Valero, GN Hortobagyi, B
Arun. Clinical Course of Breast Cancer Patients with Metastases
Limited to the Liver Treated with Chemotherapy. Cancer J 2008;
14(1):62-68;
A32. Coskun U, Buyukberber S, Yaman E, Uner A, Er O, Ozkan M,
Dikilitas M, Oguz M, Yildiz R, B DY, Kaya AO, Benekli M. Xelox
(capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of
unresectable liver metastases in colorectal cancer patients. Neoplasma
2008;55(1):65-70;
A33. O Er, S Mistik, M Ozkan, A Ozturk, M Altinbas. Factors related to
complementary/alternative medicine use among cancer patients in
Central Anatolia. Tumori 2008; 94: 833-837;
A34. Dogu GG, Ozkan M, Ozturk F, Dikilitas M, Er O, Ozturk A. Triplenegative
breast cancer: immunohistochemical correlation with basaloid
markers and prognostic value of survivin. Med Oncol. 2009 Jan 21;
5
A35. Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D,
Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F,
Gormley M, Quong AA, Rui H, Frank PG, Milliman JN, Knudsen ES, Zhou
J, Wang C, Pestell RG, Lisanti MP. Loss of caveolin-3 induces a lactogenic
microenvironment that is protective against mammary tumor formation.
Am J Pathol. 2009 Feb;174(2):613-29;
A36. Karaoglu A, Arslan UY, Ozkan M, Kalender ME, Alici S, Coskun U,
Gumus M, Celenkoglu G, Er O, Sevinc A, Buyukberber S, Alkis N, Benekli
M. Efficacy and toxicity of gemcitabine and pegylated liposomal
doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian
cancer. Asian Pac J Cancer Prev 2009 Jan-Mar; 10 (1): 63-66;
A37. Coskun U, Alkis N, Celenkoglu G, Buyukberber S, Ozkan M, Camci
C, Uner A, Er O, Aslan UY, Sevinc A, Tokluoglu S, Ozturk B, Yildiz R,
Benekli M; Anatolian Society of Medical Oncology. Gemcitabine combined
with uracil-tegafur in patients with advanced pancreatic cancer. J Natl
Med Assoc. 2009 Aug;101(8):761-764;
A38. Er O. Cancer stem cells in solid tumors. Onkologie. 2009
Oct;32(10):605-609;
A39. Karaca H, Lale A, Dikilitas M, Ozkan M, Er O. Recovery of
paraneoplastic hypercalcemia by sunitinib treatment for renal cell
carcinoma: a case report and review of the literature. Med Oncol. 2009
Oct 15;
A40. Hasan Senol COSKUN, Mustafa ALTINBAS, Ozlem ER, Figen
OZTURK, Hatice KARAMAN, Serdar SOYUER, Metin OZKAN, Isin SOYUER.
Human epidermal growth factor receptor 2 oncoprotein expression in
breast cancer patients from central Anatolia, Turkey. Asia Pacific Journal
of Clinical Oncology 2009;5:209-211;
B. Oral and Poster Presentations at International Meetings:
B1. H. S. Coskun, B. Eser, M. Cetin, A.Unal, M. Altınbas, O. Er, E.
Karahacıoğlu, B. Kaplan. Hodgkin Disease: results of single center in
Central Anatolia of Turkey. American Society of Clinical Oncology. Thirtysixth
Annual Meeting May 20-23, 2000-New Orleans, LA, USA;
B2. Ozlem Er, H.Senol Coskun, Mustafa Altınbas, Bulent Eser, Muzaffer
Keklik, Mustafa Cetin, Eray Karahacıoğlu, Ali Unal. Efficacy of vinorelbine
and doxorubicine combination chemotherapy in metastatic breast
cancer. European School of Oncology 2nd Milan Breast Cancer Congress
June 14-16, 2000,Milan, Italy;
B3. A Unal, M Cetin, B Eser, S Gucer, M Tayyar, O Er, HS Coskun.
Activated protein C resistance in Turkish women with pre-eclampsia. 5th
Annual Meeting of the European Haematology Association, p:500, 25-28
June 2000, Birmingham, UK;
B4. H. Senol Coskun, Ozlem Er, Mustafa Altınbas, Fatih Tanrıverdi,
Bulent Eser, Ali Unal, Mustafa Cetin. Adjuvant treatment of locally
advanced gastric cancer. A retrospective analysis. 25th European
Society for Medical Oncology Congress, 13-17 October 2000, Hamburg,
Germany. Annals of Oncology 2000, 11(Suppl 4): p117;
B5. Ali Unal, Bulent Eser, Mustafa Cetin, Mustafa Altınbas, Eray
6
Karahacıoğlu, Olgun Kontas, Bunyamin Kaplan, Ozlem Er, Senol
Coskun. Clinico-pathologic characteristics of non-Hodgkins lymphoma
patients at single center in Central Anatolia. 25th European Society for
Medical Oncology Congress, 13-17 October 2000, Hamburg Germany.
Annals of Oncology 2000, 11(Suppl 4): 102;
B6. M Altınbas, HS Coskun, O. Er, M Ozkan, B Eser, A Unal, M Cetin.
Prospective randomized study of epirubicine cyclophosphamide and
vincristine combination chemotherapy (CEV) + low molecular weight
heparin (LMWH) in small cell lung cancer. Proceedings of ASCO VOL 20
2001; 321a;
B7. Ozlem Er, HS Coskun, M.Altınbas, B.Eser, M.Cetin, A.Unal.
Epidemiological characteristics and results of adjuvant treatment of
colorectal cancer patients from Erciyes University Oncology Hospital in
Turkey. Proceedings of ASCO vol 20 2001;114b;
B8. Ozlem Er, HS Coskun, M.Altınbas, İ.Gulmez, B.Eser, M.Cetin,
A.Unal. Cisplatin and etoposide versus cisplatin and vinorelbine:A
retrospective comparison in patients with advanced nonsmall cell lung
cancer. International Symposium Lung Cancer and Bronchoscopy 29
Aug-1Sep 2001;
B9. M.Altınbas, O. Er, HS Coskun, S.Soyuer, A.Unal, E,Karahacıoğlu.
Palliative chemotherapy in inoperable or metastatic pancreatic
carcinoma. 4th International Conference on Biology, Prevention and
Treatment of Gastrointestinal Malignancies Sep 6-8,2001; 84;
B10. M.Altınbas, O. Er, HS Coskun, E.Ekici, İ.Gulmez, M.Ozesmi.
Ifosfamide, mesna and interferon alfa combination therapy in malignant
mesothelioma:results of a single center in central anatolia, Turkey.
European J Cancer 2001: vol 37 sup 6; 46-47;
B11. HS Coskun, O. Er, M.Altınbas, B.Eser, A.Unal, M.Cetin. Efficacy of
cisplatin etoposide combination in anthracycline refractory metastatic
breast cancer. The Breast Journal 2001;7(5): 43;
B12. HS Coskun, O. Er, M.Altınbas, O. Coban, M.Cetin, B.Eser.
Docetaxel and doxorubicin combination in salvage therapy of metastatic
breast cancer. The Breast Journal 2001;7(5): 43-44;
B13. Ozlem Er, HS Coskun, M.Altınbas, B.Eser, A.Unal, M.Cetin.
Paclitaxel and epirubicin combination therapy in metastatic breast cancer
patients. The Breast Journal 2001;7(5): 69;
B14. Ozlem Er, HS Coskun, I. Soyuer, M.Altınbas. Late onset of local
recurrence and distant metastases from breast cancer. The Breast
Journal 2001;7(5): 71;
B15. Ali Unal, Mustafa Cetin, Bulent Eser, Turkan Patıroğlu, Senol
Coskun, Ozlem Er, Bunyamin Kaplan, Mustafa Altınbas. Autologous
Peripheral Blood Stem Cell Transplantation In Patients with Resistant
and/or Relapsing Lymphoma: Single center experience. Blood 2001;
98(11): 400b;
B16. M. Altınbas, F.N. Aykan, M. Erkisi, E. Buyukunal, İ. Yucel, N. Gunel,
O. Er, N, Uskent, H. Akbulut, R. Disci, H. Camlıca, D. Fırat. Alternating
combination of irinotecan with 5-fluorpuracil and folinic acid in first line
chemotherapy of metastatic colorectal cancer (a Turkish Oncology Group
7
study). American Society of Clinical Oncology. Thirty-Eighth Annual
Meeting May 18-21, 2002 Orlonda FL, USA Prog Proceedings of ASCO
Vol: 21, 2002 Abstract: 22269;
B17. Ozlem Er, Senol Coskun, Yusuf Solak, Mustafa Altınbas. Irinotecan
Plus Cisplatin Combination Against Metastatic Gastric Adenocarcinoma:
Preliminary Results of Phase II Study. American Society of Clinical
Oncology. Thirty-Eighth Annual Meeting May 18-21, 2002 Orlando FL,
USA Prog Proceedings of ASCO Vol: 21, 2002 Abstract: 2310;
B18. B.Eser, A.Unal, M. Baskol, M. Cetin, E. Cakmak, H.S. Coskun, O.
Er. Elevated transaminase levels in patients with vitamin B12 Deficiency.
7th Meeting of the European Hematology 6-9 June 2002, Italy. The
Hematology Journal 2002; 3(Supply 1): 384;
B19. A.Unal, B.Eser, O. Canoz, B. Kaplan, H.İ. Sarı, H.S. Coskun, O. Er,
M. Altınbas, M. Cetin. Clinicopathologic characteristics and prognostics
factors of primary gastrointestinal non-Hodgkin’s lymphoma. 7th Meeting
of the European Hematology 6-9 June 2002, Italy. The Hematology
Journal 2002; 3(Supply 1): 267-268;
B20. Ozlem Er, Hasan Senol Coskun, M.Altınbas, Metin Ozkan, Bulent
Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Meropenem +/-
granulocyte colony stimulating factor in treatment of febrile neutropenic
patients in cancer: Prospective randomized study. 27th ESMO Congress,
18-22 October, 2002: Nice, France, 5 (supp 717p):194;
B21. M.Altınbas, Ozlem Er, Hasan Senol Coskun, Metin Ozkan, Bulent
Eser, Mustafa Cetin, Fevzi Altuntas, Ali Unal. Gemcitabin and cisplatin in
the treatment of advanced or metastatic pancreatic cancer. 27th ESMO
Congress, 18-22 October, 2002: Nice, France, 5 (supp 717p):194;
B22. H.Senol Coskun, Mustafa Altınbas, Ozlem ER, Figen Ozturk, Hatice
Karaman, Serdar Soyuer, Metin Ozkan, Isın Soyuer. HER2 expression in
Turkish breast cancer patients from a single center. 27th ESMO
Congress, 18-22 October, 2002: Nice, France, 5 (supp 41p):194;
B23. Ozlem Er, Yusuf Ozkul, Mustafa Altinbas, Sebnem Gursoy, H.Senol
Coskun, Metin Ozkan, Serpil Tekin, Hilal Akalin. K-ras codon 12
mutations in colorectal cancer patients. American Society of Clinical
Oncology Annual Meeting May 31-June 3, 2003 Chicago Illinois, USA
Prog Proceedings of ASCO 2003 Vol 22 p308, no:1238;
B24. Mustafa Altinbas, Metin Ozkan, Ozlem Er, Hatice Everest, H.Senol
Coskun, Ahmet Menku, Yasemin Cihan, Bunyamin Kaplan. Adjuvant
radiotherapy and fotemustine in treatment of anaplastic astrocytoma
and glioblastoma multiforme patients. ASCO Annual Meeting May 31-
June 3, 2003 Chicago Illinois, USA Prog Proceding of ASCO 2003 Vol 22,
p:115, no:459;
B25. Bunyamin Kaplan, Mustafa Altınbas, Celalettin Eroğlu, Eray
Karahacıoğlu, Ozlem Er, Metin Ozkan, Mehmet Bilgin, Ozlem Canoz, İnci
Gulmez, Mustafa Gulec. A phase II study of weekly paclitaxel (PTX) and
carboplatin (CBDCA) with concurrent thoracic radiation therapy (TRT)
followed by consolidation chemotherapy with PTX/CBDCA for stage III
unresectable non-small cell lung cancer (NSCLC). ASCO Annual Meeting
May 31-June 3, 2003 Chicago Illinois, USA Prog Proceedings of ASCO
2003 Vol 22, p:704, no:2832;
B26. B Eser, F Altuntas, B Kaplan, O Canoz, M Ozkan, O Er, HS Coskun,
8
K Gundogan, M Cetin, A Unal. Results of first line treatment in Hodgkin’s
disease: Single center experience. 8th Annual Congress of the European
Haematology Association, 12-15 June 2003, Lyon, France, no:0355;
B27. F Altuntas, B Eser, O Canoz, O Er, M Ozkan, B Kaplan, A Sahin, M
Cetin, A Unal. Fludarabine and fludarabine based combination
chemotherapy in chronic lymphocytic leukemia/lymphoma. 8th Annual
Congress of the European Haematology Association, 12-15 June 2003,
Lyon, France, no:0623, p:190;
B28. Ozlem Er, Metin Ozkan, Mustafa Altinbas, H. Senol Coskun, Bulent
Eser, Fevzi Altuntas, Mustafa Cetin, Ali Unal. 5-fluorouracil+interferon
alfa+ interleukin-2 chemoimmunotherapy in metastatic renal cell cancer
patients. ASCO 40th Annual Meeting 2004 New Orleans, USA Prog
Proceedings of ASCO Vol 23, 2004;
B29. H.S. Coskun, O. Er, M. Ozkan, B. Eser, M. Altinbas. Adjuvant
sequential docetaxel and cyclophosphamide-doxorubicin combination in
operable breast cancer patients. Proceedings of ASCO Vol 23 2004;81;
B30. M. Altinbas, B. Kaplan, K. Ucar, M. Ozkan, E. Karahacioglu, O. Er,
C. Kucuk, I. Soyuer. ‘5-FU plus lucovorin (Mayo Regimen) for concurrent
chemoradiotherapy after surgery in patients with resectable locally
advanced gastric carcinoma: Preliminary results of a phase II study.
‘Proceeding of ASCO vol 22 2004;4196;
B31. Mustafa Altinbas, Metin Ozkan, Ozlem Er, Ramazan Coskun,
Bunyamin Kaplan, Oguz G. Yildiz, Bulent Eser, Ismail Sari, Ramazan
Demir. Phase II study of Cisplatin-Etoposide (CE) combination
chemotherapy + low molecular weight heparin (LMWH) in small cell lung
cancer (SCLC). Annals of Oncology 2004, Suppl 3 (15):162;
B32. Ozlem Er , Debbie Frye, Kristine Broglio, Vicente Valero, Gabriel
N. Hortobagyi, Banu Arun. Clinical Course Of Breast Cancer Patients wıth
Liver Metastases Only Treated With Chemotherapy. Annals of Oncology
2004, Suppl 3 (15):42;
B33. M. Ozkan, I. Sari, I. Kocyigit, O. Er, B. Eser, Y. Ozkul, G. Gokoz,
M. Cetin, M. Altinbas. “Trombosis in Cancer Patients” (P1002), Journal of
trombosis and Haemostasis, 2005, Vol3 (Suppl 8);
B34. O. Er, M. Ozkan, S. Coskun, G. Dogu, M. Altinbas.
“Cisplatin+gemcitabine versus cisplatin+vinorelbine in patients with
stage IV non-small cell lung cancer (NSCLC): Results of single center
experience” (P481) Lung Cancer, 49 (Suppl 2), 243 (2005);
B35. I. Soyuer, S. Soyuer, K. Ucar, O. G. Yildiz, O. Orhan, M. Ozkan, O.
Er, M. Altinbas, B. Kaplan “Prognostic significance of CD9 and NF-kb in
gastric carcinoma patients treated with surgery and adjuvant
chemoradiotherapy” (P2-017) XXIII. World Congress of Pathology and
Laboratory Medicine 199 (2005);
B36. Coşkun HŞ, Yilmaz O, Alanoğlu G, Şahin M, Er Ö, Ergürhan İlhan
İ. Chemotherapy associated anemia in solid tumor patienst from
Anatolia. ASCO 41st Annual Meeting Proceedings. J Clinical Oncology
2005; 23: (16S): 729s, P: 8257;
B37. M Altinbas, AT Ersozlu, M Dikilitas, GG Dogu, M Ozkan, O Er. Early
osteoporosis risk in premenopausal women with breast cancer after
9
ovarian ablation. 31st ESMO Congess, Annals of Oncology 2006; 17: S9:
316;
B38. M Ozguroglu, T Evrensel, O Er, H Turna, T Yanmaz, O Yildiz, N
Mandel, S Serdengecti. Phase II trial of a combination of weekly
docetaxel and four-weekly carboplatin in the first line treatment of
advanced non-small cell lung cancer. 31st ESMO Congess, Annals of
Oncology 2006; 17: S9: 756P;
B39. M Ozkan, A Okur, M Dikilitas, E Mavili, O Er, GG Dogu, M Altinbas,
M Gulec. The effect of concurrent chemotherapy and low molecular
weight heparin (dalteparin) on tumor angiogenesis in patients with small
cell lung cancer: Radiologic evaluation-preliminary results. 31st ESMO
Congress, Annals of Oncology 2006; 17: S9: 811;
B40. G Demir, N Zengin, O Yildiz, G Dogusoy, F Aykan, O Er, A
Isikdogan, S Turhal, U Yilmaz, Suayib Yalcin. The role of lymph nodes on
disease free survival in operated gastric cancer (Turkish Oncology Group
Study). 31st ESMO Congress, Annals of Oncology 2006; 17: S9: 1100P;
B41. G Demir, N Zengin, O Yildiz, S Ozdamar, F Aykan, O Er, M Ilhan, S
Turhal, U Yilmaz, Suayib Yalcin. Clinical profile of gastric cancer in
Turkey: Factors effecting disease free survival and relapse (Turkish
Oncology Group Study). 31st ESMO Congress, Annals of Oncology 2006;
17: S9: 1139;
B42. M Ozkan, M Dikilitas, I Kocyigit, O Er, I Sari, GG Dogu, B Eser, Y
Ozkul, A Unal, M Altinbas. Thrombosis and cancer:Clinical, laboratuary
and genetic evaluation. 31st ESMO Congress, Annals of Oncology 2006;
17: S9: 1048P;
B43. O Er, M Inanc, M Ozkan, GG Dogu, M Dikilitas, A Ozturk.
Predicitive value of D-Dimer and LDH levels in response to chemoterapy
in metastatic colorectal cancer patients. Journal of Clinical Oncology,
2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No 18S,
2007:14568;
B44. B Yalcin, S Yalcin, A Buyukcelik, O Sencan, M Dogan, M Turk, F
Ozdemir, A Isikdogan, O Er, H Akbulut, F Icli. Opinions of the Turkish
population on cancer and being informed for the diagnosis of cancer: An
opinion survey. Journal of Clinical Oncology, 2007 ASCO Annual Meeting
Proceedings Part I. Vol 25, No 18S, 2007:19680;
B45. A Sevinc, C Camci, I Sari, ME Kalender, O Er, I Soyuer, M Dikilitas,
U Yilmaz, O Sagol, A Alacacioglu. Cyclooxygenase-2 expression in
gastrointestinal stromal tumors. J Clin Oncol 2008: 26 (May 20 Suppl;
abstr 15643);
B46. Agnieszka K. Witkiewicz, Thai H. Tran, Ozlem Er, Terry Hyslop,
Hallgeir Rui. Nuclear expression of transcription factors Stat5a and
Stat5b confers favorable prognosis in breast cancer. Proceedings of the
100th Annual Meeting of the American Association for Cancer Research;
2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract
nr {5286};
